1.Quantitative study on ischemic and antiischemic myocardium injury in cultured myocardial cell
Chinese Journal of Pathophysiology 1986;0(01):-
The ischemic myocardium in cultured myocardial cell of newborn rat and treated with Sodium Selenite(Se) and Fructose-1, 6-diphosphate(FDP) were studied comparatively by means of morphometry and quantitative cytochemistry. The area of myocardial cell and mitochondrion and the content of succinic dehydrogenase (SDH) in myocardial cell were quantitated by texture analysis system (TAS). Lipid peroxidation(LPO) and the myocardial cell beat function were observed. The results showed that the changes of the mitochondrion area interrelated with its number remarkabiy. When the mitochondrion area enlarges more than two fold, the destruction of mitochondrion is remarkable. Both Se and FDP can protect the ischemic myocardial cell, but the effects Se on forestalling destruction of mitochondrion, maintaining vitality of SDH and reducing content of malondialodehyde (MDA) are more powerful than FDP, and the effects of FDP on reducing edema of myocardial cell and mitochondrion, improving myocardial cell beat function are better than Se.
2.Treatment for Palmar-Foot Hyperhidrosis Based on Spleen and Stomach
Chinese Journal of Information on Traditional Chinese Medicine 2017;24(4):113-114
Palmer-foot hyperhidrosis is one kind of focal hyperhidrosis, with symptoms of sweating hands or feet. Some people even have sweat dripping off their hands or feet. This article studied the views of TCM on palmer-foot hyperhidrosis, expounded the pathological and physiological relationship between palmer-foot hyperhidrosis and spleen and stomach, and proposed that clinical treatment should be based on the syndrome differentiation and treatment of spleen and stomach, which can achieve certain efficacy.
4.Development of study on tumour epidemiology in China.
Chinese Journal of Preventive Medicine 2007;41 Suppl():1-2
China
;
epidemiology
;
Humans
;
Neoplasms
;
epidemiology
5.Diagnosis and treatment of patellar chondroblastoma.
China Journal of Orthopaedics and Traumatology 2013;26(12):1059-1062
Chondroblastoma of the patella, rare occurred in patellar,is a kind of an uncommon benign bone tumor. Compared with giant cell tumor, the morbidity of chondroblastoma is lower. Meanwhile, its clinical manifestations are various, and images are very complicated. Therefore, the understanding of this kind of tumors may be limited even to the orthopedist. The differences of patellar chondroblastoma between other tumor in X-ray, CT and MRI is a spot in recent years. Sometimes patellar chondroblastoma coexists with aneurysmal bone cyst, which is a challenge to obtain an accurate pathological and radiological diagnosis. For the treatment, curettage and bone grafting is one the most popular method, but whether to perform a biopsy before surgery still remain controversy. Some new technique still has an unknown prospect for the treatment such as radiofrequency ablation.
Bone Neoplasms
;
diagnosis
;
surgery
;
Chondroblastoma
;
diagnosis
;
surgery
;
Humans
;
Patella
;
surgery
7.Alteration of [Ca~(2+)]_i in pulmonary artery smooth muscle of pulmonary artery hypertension rats
Chinese Pharmacological Bulletin 1986;0(05):-
Aim To investigate the changes of [Ca2+]i in the pulmonary artery smooth muscle cells of PAH rats induced by MCT.Methods PAH rat model was established by MCT intraperitoneal injection.The PASMCs were primarily cultured and loaded with Fura-2/AM.Effects of Ryanodine receptor agonists on intra-cellular calcium were measured by Fluorescence microscopy Results After being given 10 nmol?L-1 Ryanodine,the concentration of [Ca2+]i in control group increased by(93.31?12.41)nmol?L-1;and the concentration in PAH group increased by(141.71?13.59)nmol?L-1(P
8.Favorable outcome of ischemic stroke in patients pretreated with statins
Chinese Journal of Practical Internal Medicine 2006;0(21):-
Objective To evaluate the independent effect of premorbid statins on incident ischemic stroke severity and outcome at discharge.Methods We included consecutive patients with ischemic stroke and recorded demographic data,vascular risk factors,Oxfordshire Classification,the method of treatment National Institutes of Health Stroke Scale(NIHSS)score,previous statins treatment,and outcome discharge.We analyzed the data using univariate methods and a logistic regression with the dependent variable of good outcome(Barthel Index,BI 95 to 100).Results A total of 185 individuals met study criteria:57 patients were on statins agents prior to admission and 128 were on no statins.Pretreatment with statins was associated with lower presenting median NIHSS(6.0 vs 13.0,P
9.The Clinical Effect of Aldose Reductase Inhibitor on Patients with Diabetic Neuropathy
Chinese Journal of Prevention and Control of Chronic Diseases 2006;0(02):-
Objective To investigate the clinical effect and safety of Epalrestat,an aldose reductase inhibitor(ARI),on patients with diabetic neuropathy.Methods 80 patients with diabetic neuropathy were randomly divided into two groups,one group were treated with Epalrestat,the other was treated with VitB12 for 16 weeks.All patients were measured on their symptoms,the physical signs and SNCV of medial nerve,ulnar nerve,peroneal nerve and tibial nerve during the treatment.Results The degrees of improvement were similar between the two groups.The subjective symptom and physical signs were significantly improved(P
10.Study on Cytotoxic Effect and Antitumor Effect of Paclitaxel Liposome
Acta Medicinae Universitatis Scientiae et Technologiae Huazhong 2001;30(1):46-49
The cytotoxic effect and antitumor effect of paclitaxel liposome were studied by using MTT assay method in vitro and in vivo antitumor test. The inhibitory rate of paclitaxel liposome on human ovarian cancer cell COC1 was 78.48 %, 84.90 %, 93.53 % respectively at the concentrations of 22.5 μg/ml, 45 μg/ml, 90 μg/ml respectively. Under the doses of 5 mg/(kg*d) and 10 mg/(kg*d) for 8 days, the inhibitory rate of paclitaxel liposome against xenograft of solid Ehrlich tumor in mice was 32.47 % and 54.63 % respectively (P<0.01). The weight change rate of the mice was 22.11 % and 21.16 % respectively. It was suggested that paclitaxel liposome possessed in vitro and in vivo antitumor activities. The toxicity of liposomal paclitaxel was lower than that of free paclitaxel.